title: Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
authors.affiliation: Department of Internal Medicine, University of Cincinnati Medical Center, Ohio, USA.
authors.forename: V R
authors.initials: VR
authors.lastname: Peddi
authors.forename: S
authors.initials: S
authors.lastname: Kamath
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: R
authors.initials: R
authors.lastname: Munda
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation; D012189:Retrospective Studies; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3